Actinium Pharmaceuticals
ATNM
#10525
Rank
ยฃ25.04 M
Marketcap
ยฃ0.80
Share price
2.86%
Change (1 day)
-37.05%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -ยฃ18.92 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.09 Million. In 2025 the company made an earning of -ยฃ26.79 Million, an increase over its 2024 earnings that were of -ยฃ31.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ18.92 Million-29.38%
2025 -ยฃ26.79 Million-13.95%
2024 -ยฃ31.13 Million-18.87%
2023 -ยฃ38.38 Million52.24%
2022 -ยฃ25.21 Million36.61%
2021 -ยฃ18.45 Million11.48%
2020 -ยฃ16.55 Million1.46%
2019 -ยฃ16.32 Million-7.37%
2018 -ยฃ17.61 Million-11.46%
2017 -ยฃ19.89 Million10.67%
2016 -ยฃ17.98 Million15.7%
2015 -ยฃ15.54 Million-14.86%
2014 -ยฃ18.25 Million129.19%
2013 -ยฃ7.97 Million-8.55%
2012 -ยฃ8.71 Million
2010 ยฃ0 M-152.15%
2009 -ยฃ0.02 Million-39.8%
2008 -ยฃ0.02 Million120.29%
2007 -ยฃ0.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-ยฃ27.49 Million 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.14 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA